Join our Community
Support ToI and remove all ads
Learn more
English
العربية
Français
فارسی
עברית
Get The Daily Edition
Account
Sign In
search
search
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Weekly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Get the Daily Edition
submit
Follow us
Facebook
Twitter
© 2023 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
search
Teva Pharmaceuticals
Advertisement
All
(257)
Kåre Schultz
(29)
opioids
(21)
pharmaceuticals
(21)
Copaxone
(20)
November 16, 2022, 8:09 pm
No link established between teen’s death and painkiller banned in US
Health Ministry panel that probed case of Liron Jazatti, 19, who died after taking dipyrone, finds it’s ‘impossible to link the incident to taking the drug’
By
ToI Staff
November 9, 2022, 11:56 pm
Israeli teen dies after taking painkiller banned in US — report
Optalgin, available over the counter in Israel but restricted elsewhere, known to cause dangerous side effects that can lead to death
By
Ash Obel
November 3, 2022, 8:39 am
Walking on sunshine: Shoresh sandals factory converts to 100% solar energy
Company says it created its own mini-grid with solar panels everywhere and switched its fleet to all-electric, as other firms also eye ways to go net zero on carbon emissions
By
Sue Surkes
September 28, 2022, 2:08 pm
Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup
AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials
By
Ricky Ben-David
July 27, 2022, 10:34 pm
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits
Generic drugmaker says it agreed to contribute sum in cash and medications to states, local governments and tribes for its role in epidemic
By
GEOFF MULVIHILL
July 12, 2022, 10:16 pm
Israel’s Teva, US Allergan agree to pay $54 million in San Francisco opioid lawsuit
Affiliate of Israel pharmaceutical giant says settling federal lawsuit is a step toward getting life-saving treatment to addicts, but doesn’t admit liability or wrongdoing
By
AP
March 30, 2022, 11:09 pm
Teva to settle opioid-related claims in Florida for $117 million
In latest settlement, mirroring past ones, US subsidiary of Israeli generic drugmaker to provide over $84m worth of treatment medicines
By
Ricky Ben-David
March 25, 2022, 11:35 am
Israeli lab says it has made safe a powerful — but toxic — cancer treatment
The research has been snapped up by pharmaceutical giant Teva, and according to the lead author could mean an ‘arsenal of new drugs’
By
Nathan Jeffay
March 22, 2022, 10:54 am
Teva reaches $21m settlement with Rhode Island over opioid-related claims
Agreement will also see US subsidiary of Israeli generic drugmaker provide over $78m worth of treatments that aid in addiction recovery, prevention
By
Ricky Ben-David
February 8, 2022, 12:06 am
Teva reaches $150 million deal with Texas to settle opioid-related claims
Agreement with US subsidiary of Israeli pharmaceutical giant also requires it to provide $75m-worth of generic medicine doses that aid in opioid addiction and recovery
By
Ricky Ben-David
December 31, 2021, 1:53 am
New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis
Pharma giant says it plans to appeal after court says firm was ‘deceptive’ in marketing two cancer drugs containing fentanyl for other types of pain
By
Jennifer Peltz
December 30, 2021, 2:01 pm
Daily Briefing Dec. 30 – Knesset ministers opine and Teva takes on cannabis
Tech Israel’s Ricky Ben David talks about Teva’s cannabis entry and the Facebook bill, as US correspondent Jacob Magid discusses his interviews with Nachman Shai and Merav Michaeli
By
ToI Staff
December 27, 2021, 11:27 pm
Teva makes first foray into medical cannabis sector, with new distribution deal
Israeli pharma giant signs agreement with Cannbit-Tikun Olam to produce THC and CBD oils for Israeli, Palestinian Authority markets
By
Ricky Ben-David
December 25, 2021, 9:02 am
Accused of complicity in opioid crisis, Teva launches nasal spray to treat overdoses
Company says its generic version of Narcan is the first to arrive in markets; firm faces multiple legal challenges for allegedly stoking opioid epidemic
By
ToI Staff
October 14, 2021, 6:48 pm
New innovation lab brings together pharma, biotech giants for AI therapeutics
Pfizer, Merck, Teva, Amazon form consortium that runs AION Labs, an Israeli facility that will focus on harnessing artificial intelligence in drug development
By
Ricky Ben-David
Load More
Advertisement
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure:
[email protected]
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.